These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19925445)

  • 41. Management of oral mucositis in patients who have cancer.
    Lalla RV; Sonis ST; Peterson DE
    Dent Clin North Am; 2008 Jan; 52(1):61-77, viii. PubMed ID: 18154865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis.
    Ong ZY; Gibson RJ; Bowen JM; Stringer AM; Darby JM; Logan RM; Yeoh AS; Keefe DM
    Radiat Oncol; 2010 Mar; 5():22. PubMed ID: 20233440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and proctoscopic evaluation of topical formalin application in the treatment of chronic radiation proctitis.
    Eriksen PL; Tougaard RS; Tøttrup A
    Scand J Surg; 2013; 102(2):96-100. PubMed ID: 23820684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Potential Role of Probiotics in Cancer Prevention and Treatment.
    Yu AQ; Li L
    Nutr Cancer; 2016; 68(4):535-44. PubMed ID: 27144297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review.
    Plevová P
    Oral Oncol; 1999 Sep; 35(5):453-70. PubMed ID: 10694945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-inflammatory agents in the management of alimentary mucositis.
    Lalla RV; Schubert MM; Bensadoun RJ; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):558-65. PubMed ID: 16565821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
    Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
    J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor.
    Beck PL; Wong JF; Li Y; Swaminathan S; Xavier RJ; Devaney KL; Podolsky DK
    Gastroenterology; 2004 Mar; 126(3):796-808. PubMed ID: 14988834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation induced oral mucositis: a review of current literature on prevention and management.
    Mallick S; Benson R; Rath GK
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2285-93. PubMed ID: 26116012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
    Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
    Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of probiotics for prevention of radiation-induced diarrhea.
    Delia P; Sansotta G; Donato V; Frosina P; Messina G; De Renzis C; Famularo G
    World J Gastroenterol; 2007 Feb; 13(6):912-5. PubMed ID: 17352022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats.
    Mi H; Dong Y; Zhang B; Wang H; Peter CCK; Gao P; Fu H; Gao Y
    Cell Physiol Biochem; 2017; 42(6):2330-2341. PubMed ID: 28848081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probiotic therapy reduces inflammation and improves intestinal morphology in rats with induced oral mucositis.
    Gerhard D; Sousa FJDSS; Andraus RAC; Pardo PE; Nai GA; Neto HB; Messora MR; Maia LP
    Braz Oral Res; 2017 Jul; 31():e71. PubMed ID: 28678976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review.
    López-Gómez L; Alcorta A; Abalo R
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review article: new insights into the pathogenesis of radiation-induced intestinal dysfunction.
    MacNaughton WK
    Aliment Pharmacol Ther; 2000 May; 14(5):523-8. PubMed ID: 10792113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of probiotics available to modify gastrointestinal flora.
    Gismondo MR; Drago L; Lombardi A
    Int J Antimicrob Agents; 1999 Aug; 12(4):287-92. PubMed ID: 10493604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis.
    von Bültzingslöwen I; Brennan MT; Spijkervet FK; Logan R; Stringer A; Raber-Durlacher JE; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):519-27. PubMed ID: 16775647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prophylactic use of probiotics in the prevention of radiation therapy-induced diarrhea.
    Visich KL; Yeo TP
    Clin J Oncol Nurs; 2010 Aug; 14(4):467-73. PubMed ID: 20682502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The potential of mesenchymal stem cells in the management of radiation enteropathy.
    Chang PY; Qu YQ; Wang J; Dong LH
    Cell Death Dis; 2015 Aug; 6(8):e1840. PubMed ID: 26247725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the Use of Anti-inflammatory Agents to Manage Chemotherapy-induced Oral and Gastrointestinal Mucositis.
    Mahendran VJ; Stringer AM; Semple SJ; Song Y; Garg S
    Curr Pharm Des; 2018; 24(14):1518-1532. PubMed ID: 29629657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.